1.195DKK+7.17%Mkt Cap: 51.62M DKKP/E: —Last update: 2026-05-13
Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally. It offers medical cannabis oil products, including THC, THC/CBD…
Industry Peers
Drug Manufacturers - Specialty & Genericloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
P/B2.72
P/S5.59
EV/EBITDA347.24
EV/Revenue5.68
EPS (TTM)-0.06
EPS (Forward)—
Cash Flow & Leverage
FCF Yield-6.82%
FCF Margin-38.07%
Operating CF-7.20M DKK
CapEx (TTM)—
Net Debt/EBITDA5.75
Net Debt868.52K DKK
Technical
SMA 501.095 (+9.1%)
SMA 2001.336 (-10.6%)
Beta0.50
S&P 52W Chg24.23%
Avg Vol (30d)202.02K
Avg Vol (10d)307.69K
Technical Indicators
RSI (14)52.8
MACD0.0325
MACD Signal0.0278
MACD Hist.+0.0047
BB Upper1.388 DKK
BB Middle1.129 DKK
BB Lower0.8706 DKK
BB Width45.79%
ATR (14)0.1370 DKK
Vol Ratio (20d)0.68x
52W Range
0.340035% of range2.800
52W High2.800 DKK
52W Low0.3400 DKK
Profitability
Gross Margin17.42%
EBITDA Margin1.64%
Profit Margin-34.05%
Oper. Margin-11.29%
ROE-25.24%
ROA-18.91%
Revenue Growth284.20%
Earnings Growth—
Balance Sheet
Debt/Equity0.21
Current Ratio1.63
Quick Ratio0.79
Book Value/Sh0.4390 DKK
Cash/Share0.0150 DKK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 DKK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.43.20M
Float33.00M
Insiders21.50%
Institutions0.00%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap51.62M DKK
Enterprise Value52.49M DKK
Revenue (TTM)9.24M DKK
Gross Profit1.22M DKK
Net Income (TTM)-2.39M DKK
Revenue/Share0.2250 DKK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4
Last Price1.195 DKK
CountryDK
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—